TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
It’s not just the efficacy and safety of the produ... See more
Dec, 30, 2022
The analyst comments "TGTX stock is up >15... See more
Divihomes is Now Live
A new search platform that matches you with the best home improvement service providers in your area.
Instant Search & Match with Top Contractors
Instant Communication with Local Contractors
Millions of Unbiased User Reviews
100% Free Quotes from Top-Notch Contractors
SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Dec, 22, 2022
The power of a very low cost basis.
Dec, 2, 2022
$SAVA I’m so excited because my cost is average fo... See more
Mar, 22, 2023
$COST almost!
Mar, 22, 2023
$COST this dude 🤡🤣🤣🤣
Mar, 22, 2023
$COST The bullish trend in the options market suggests a positive outlook for the stock We are seeing the $450 CALL having heavy activity which expire in 38 days.
Mar, 21, 2023
$COST 💵long 💅
Mar, 20, 2023
$COST 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
Mar, 20, 2023
$COST nice wedge here 🫡🔒 all I gottta say 🤫
Mar, 18, 2023
$COST Love Costco as much as anyone
Mar, 17, 2023
$COST 2hr looking bullish, she wanna touch the 200 day which is 296, juicy
Mar, 16, 2023
$COST The chart points towards an optimistic outlook for the stock.
Mar, 15, 2023
$COST Always a buy in the 470s, congratulations to those who got it this a.m.
Feb, 4, 2023
It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 22, 2022
The power of a very low cost basis.
Dec, 2, 2022
$SAVA I’m so excited because my cost is average for my shares is $25.87 that’s why hahahahaha you have to be a Short and I’m semi retired hahahaha
Nov, 22, 2022
$SAVA Mike cost this morning was $31.68 This morning not too bad